Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Congress 2022: Industry Sponsored Satellite Symposia – Gastrointestinal Tumours, Lower Digestive

ESMO-Congress-2022-1000x250

Friday 9 September

Advancing Tailored Therapies in NSCLC and KRASG12C-Driven Tumors

01-Advancing-Tailored-Therapies-in-NSCLC-and-KRAS-Driven-Tumors-MIRATI-thumb

Friday, 10:15 - 11:45
View the satellite invitation

GI Cancer and Immuno-Oncology Today: Best Practice and Clinical Challenges

05-GI-Cancer-and-Immuno-Oncology-Today-Best-Practice-and-Clinical-Challenges-BRISTOL-thumb

Friday, 10:15 - 11:45
View the satellite invitation

From Complex to Simple: The Journey to Strategic Sequencing in the Management of mCRC

12-From-Complex-to-Simple-MERCK-Thumb

Friday, 18:00 - 19:30
View the satellite invitation

Saturday 10 September

Navigating through the Rapidly Evolving Treatment Landscape for GI Cancers, a Clinical & Patient Centric Approach Towards Implementing Immunotherapy

14-Navigating-Through-the-Rapidly-Evolving-Treatment-Landscape-for-GI-Cancers-MSD-thumb

Saturday, 13:00 - 14:30
View the satellite invitation

Interpreting Real-World Data to Better Manage Patients with Metastatic Colorectal Cancer

08-Interpreting-Real-World-Data-to-Better-Manage-Patients-with-Metastatic-Colorectal-Cancer-SERVIER-thumb

Friday, 18:00 - 19:30
View the satellite invitation

Sunday 11 September

The Current and Emerging Role of ADCs in Cancer Therapy

36-The-Current-and-Emerging-Role-of-ADCs-in-Cancer-Therapy-DAIICHI-Thumb

Sunday, 13:00 - 14:30
View the satellite invitation

Immune Checkpoint Inhibitors in Mismatch Repair Deficient Solid Tumors: Expert Interviews

39-Immune-Checkpoint-Inhibitors-in-Mismatch-Repair-Deficient-Solid-Tumors-GSK-thumb

Sunday, 18:30 - 20:00
View the satellite invitation

Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.